ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Washington » Internal Medicine

Top Internal Medicine Prescribers in Washington

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DAVID KAUFF M.D.

Internal Medicine

867

$50.1K

215
180 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 23%

$58
Average prescription price

Avg: $56

KHANHPHONG TRINH MD

Internal Medicine

870

$23.7K

42
17 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$27
Average prescription price

Avg: $56

LORA JASMAN M.D.

Internal Medicine

875

$34.8K

97
73 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

18%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 23%

$40
Average prescription price

Avg: $56

MEGAN WHITMAN MD

Internal Medicine

922

$49.8K

92
43 are 65+

16%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $56

DANIEL QUIROZ-PORTELLA MD

Internal Medicine

927

$41.5K

124
89 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$45
Average prescription price

Avg: $56

CHRISTEN EIDAL MD

Internal Medicine

934

$52.9K

173
121 are 65+

21%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$57
Average prescription price

Avg: $56

LAUREN CARPENTER MD

Internal Medicine

939

$44.2K

37
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $56

JANE FORE MD

Internal Medicine

949

$39.6K

184
125 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

6%
prescriptions for brand name drugs

Avg: 23%

$42
Average prescription price

Avg: $56

LINDA POURMASSINA MD

Internal Medicine

949

$46.5K

179
141 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $56

ZSUZSANNA RAD M.D.

Internal Medicine

956

$57K

84
43 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 23%

$60
Average prescription price

Avg: $56

MEHRDAD KHALIGHI

Internal Medicine

957

$23.8K

101
50 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 23%

$25
Average prescription price

Avg: $56

VLADIMIR DZHASHI MD

Internal Medicine

966

$40.9K

176
95 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$42
Average prescription price

Avg: $56

PRATIMA SHARMA MD

Internal Medicine

984

$42K

81
62 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 23%

$43
Average prescription price

Avg: $56

GEMMA O KEEFFE M.D.

Internal Medicine

988

$47.7K

134
116 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $56

JAIME FRIEDMAN M.D.

Internal Medicine

1,009

$48.5K

90
85 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $56

CRAIG RILEY MD

Internal Medicine

1,025

$62K

68
46 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$61
Average prescription price

Avg: $56

ADRIAN COSMIN MD

Internal Medicine

1,027

$165K

90
67 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 23%

$160
Average prescription price

Avg: $56

JEFFREY MEEHAN M.D.

Internal Medicine

1,033

$49.8K

132
127 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $56

ANNE EACKER

Internal Medicine

1,034

$49.6K

62
44 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $56

MICHAEL MILDER MD

Internal Medicine

1,044

$628K

133
109 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$601
Average prescription price

Avg: $56

DAWIT GEBREKIDAN M.D.

Internal Medicine

1,050

$44.1K

100
47 are 65+

15%
patients receiving schedule two controlled substances

Avg: 7%

28%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$42
Average prescription price

Avg: $56

JAMES ROBERTS MD

Internal Medicine

1,055

$85K

57
46 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$81
Average prescription price

Avg: $56

KRISTIN ADAMS M.D.

Internal Medicine

1,059

$46.8K

66
60 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 23%

$44
Average prescription price

Avg: $56

FAITH REEVES MD

Internal Medicine

1,063

$63.2K

78
65 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$59
Average prescription price

Avg: $56

AMY EDDY MD

Internal Medicine

1,067

$74.7K

76
34 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

33%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$70
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank